Skip to main content
2024 Canadian Cardiovascular Congress Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Handout
Handout
Networking
Networking
On-Demand
On-Demand
Early Career Involvement
Early Career Involvement
Back

Anique Ducharme, MD, MSc, FCCS, FACCC (she/her/hers)

Professor of medicine, University of MontrealDirector Heart Failure clinic, Montreal heart Institute
CHFS, CCTN, CANCARE
University of Montreal

Dr. Ducharme is a Professor of Medicine and holder of the University of Montreal Coutu-Moisan chair for best practices in advanced Heart Failure. She is the founder and Director of the Heart Failure Clinic at the Montreal Heart Institute, president of the Canadian Heart Failure Society and was the Scientific Program Committee Chair for the Canadian Cardiovascular Congress (CCC, from 2018-2020), where she implemented a mandatory 3G politics for all workshops being presented, to promote diversity in terms of gender, geography and generation; she also led the pivot from a in-person to a fully virtual meetin for CCC2020. She has been (and still is) on the CCS Heart Failure Guidelines Committee since 2006 and is the program director for the University of Montreal Advanced Heart Failure and Cardiac transplantation fellowship program. She has published over 165 peer-reviewed articles including in the NEJM, Lancet and Circulation, 16 book chapters, 200 abstracts and 2 online university tutorial courses and is currently serving or has served on several leadership committees for large-scale studies, including GUIDE-HF, VICTOR, STICH, AF-CHF, EARTH, RELAX-HF and CHARM. She is an associate editor for the International Journal of Cardiology: Heart and Vasculature and also participates in several review panels for many journals,
Dr. Ducharme graduated from Université de Montréal in Medicine (MD) and Biomedical sciences (MSc, cardiac transplantation) (1991) and Cardiology(1996), followed by a fellowship at the Brigham & Women’s Hospital, Harvard Medical School (Boston). Since her return in 1999, she has held a position in the Non-invasive Cardiology department at the Montreal Heart Institute, where she carries out activities in echocardiography, advanced heart failure and cardiac transplantation. Her clinical and research focus is on advanced heart failure, including remodeling, pharmacological and device therapies (cardiac resynchronization therapy, percutaneous valvular interventions, pulmonary pressure monitoring, mechanical assist devices) and cardiac transplantation.

Disclosure(s): Abbott medical: Co-PI EVOLVE MR trial (Ongoing), Outreach conference in advanced heart failure (Ongoing); Astra-Zeneca: Guidelines conference sponsored by AZ (Ongoing), SYMPHONY trial - earliy detection of heart failure in the community (Ongoing); BridgeBio: Attribute TTR trial (Ongoing); Canadian Heart failure Society: Past president (member of the Executive board, voluntary work) and honorarium for conferences (Ongoing); Merck: National Leader, VITOR trial (Ongoing); Novartis: Guidelines conference sponsored by Novartis (Ongoing), HF-iDOC, PARTHENON (Ongoing); NovoNordisk: Conferences/satellite symposium at HFA (Ongoing), HERMES trial - Member of the steering Committe (Ongoing)

Presentation(s):